Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug769 | CMP-001 Wiki | 1.00 |
drug3124 | Pembrolizumab Wiki | 0.58 |
drug1116 | Control Wiki | 0.27 |
Name (Synonyms) | Correlation | |
---|---|---|
D002294 | Carcinoma, Squamous Cell NIH | 0.71 |
D000077195 | Squamous Cell Carcinoma of Head and Neck NIH | 0.71 |
D002277 | Carcinoma NIH | 0.30 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002860 | Squamous cell carcinoma HPO | 0.71 |
HP:0030731 | Carcinoma HPO | 0.30 |
Navigate: Correlations HPO
There is one clinical trial.
The documentation of vital signs is traditionally performed manually when the patient is not admitted in intensive care units, which can lead to documentary errors, long time for data acquisition and, consequently, impairment in the early identification of possible clinical deterioration. In-bed technology solutions are available to automate the collection of vital data and transfer information to a medical record or central electronic monitoring and its role in the health value chain needs further investigation. The investigators propose to evaluate the impact of the Connex Spot Monitor solution Welch Allyn (CSM / Hillrom) in conjunction with the Hillrom Connecta solution in a real world situation, conducting a cluster randomized trilal in wards of a tertiary hospital. In addition, this study aims to estimate the clinical effectiveness of a technological solution that performs an analysis of vital signs and automatically activates the rapid response team (RRT) when the pre-defined criteria are met, comparing it with the traditional manual method. The primary outcome is the number of times that the RRT fires in a timely manner.
Description: Number of rapid response team triggers activated in a timely manner.
Measure: RRT Time: 24 hoursAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports